OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - GLOBAL BLOOD THERAPEUTICS IN ownership

Back to all holdings Add to watchlist

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 85 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$152,461,000,000
+7996.7%
2,238,787
+6153.6%
2.89%
+7933.3%
Q2 2019$1,883,000,000
+126.9%
35,800
-28.4%
0.04%
+100.0%
Q2 2016$830,000,000–50,000–0.02%–
 Download
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2016
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders